Definitive Contract 75N92022C00024

Award Date 4/1/22
Potential Completion Date 3/31/26
Potential Value $3.4M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Andover, MA 01810, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $3,389,890.00 Firm Fixed Price definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for the development of a "Device System for Transcatheter Repair of Postinfarction Ventricular Septal Defect" under SBIR Topic 108. This is a Fast-Track SBIR project, with a total completion date of December 31, 2024. Transmural...
This is a $3,412,128 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for Phase I of a Fast-Track Small Business Innovation Research (SBIR) award focused on "Devices for Transcatheter Surgery". The original solicitation was part of the NIH/CDC SBIR Contract Solicitation PHS 2018-1, which sought proposals from small...
This is a $3,299,988.00 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for a Small Business Innovation Research (SBIR) Phase I research project on a "CERCLAGE FOR TREATING SECONDARY MITRAL REGURGITATION". The contract was set aside for total small business participation and has an ultimate completion date of June 30,...
This is a $2,297,559.00 Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Transmural Systems LLC, a woman-owned small business. The contract was awarded under the Small Business Innovation Research (SBIR) program, with a Topic 106 FAST-TRACK designation, for the development of an Active MRI Needle. Transmural Systems has previously received SBIR awards and grants from the National Institutes of Health and National Heart, Lung, and Blood...
This definitive contract was awarded by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Transmural Systems LLC. The $399,924 firm fixed price contract is for Phase I research under Solicitation A, which sought Small Business Innovation Research (SBIR) proposals in support of NIH and Centers for Disease Control and Prevention (CDC) agency missions. Specifically, Transmural Systems will conduct research and development of a transcatheter...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for the development of a "Closure Devices for Transcaval Access to the Abdominal Aorta" under SBIR Topic 088. The contract has a ceiling value of $2,999,999.98 and was awarded on a firm fixed-price basis. Transmural Systems...
This is a $399,352.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract was set aside for total small business participation and was awarded to Transmural Systems LLC, a woman-owned small business that provides medical device research, development, and manufacturing services. The contract supports the...
This is a $2,999,357.00 Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Transmural Systems LLC, a woman-owned small business. The contract is for Phase II of a Small Business Innovation Research (SBIR) project focused on the development of a Transcatheter Potts Shunt device. The contract has a firm fixed price pricing type and a completion date of September 20, 2026. Transmural Systems has...
This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) to Transmural Systems LLC, a woman-owned small business. The $2,199,922.00 Firm Fixed Price contract was awarded under the Small Business Innovation Research (SBIR) program to conduct research and development on tapered guidewires for transcatheter electrosurgery. Transmural Systems has prior experience supporting...
This definitive contract award of $2,998,998 to Transmural Systems LLC by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute is for Phase II of Small Business Innovation Research Topic #110. The contract will support the continued research and development of a myocardial biopsy system through September 2026. The solicitation sought proposals across over 125 topics focused on areas such as cancer treatment and infectious diseases from...

This is a $3,399,609 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for research and development of an "Intramyocardial Suture Annuloplasty System" under the NIH's Small Business Innovation Research (SBIR) program. This contract was set aside for total small business participation. Through past SBIR awards, Transmural Systems has developed various cardiovascular devices, including transcatheter repair systems and MRI-compatible medical devices. The goal of this contract is to further develop and test the "MIRTH" and "SCIMITAR" devices, which are intramyocardial suture annuloplasty systems, with the intent of obtaining FDA approval for expanded clinical trials and commercialization.

Generated 9/27/24, 9:30 AM